<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056675</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01792</org_study_id>
    <nct_id>NCT05056675</nct_id>
  </id_info>
  <brief_title>The PENG Block in Elective Hip Surgery and Its Effect on Postoperative Pain and Length of Stay.</brief_title>
  <official_title>The PENG Block in Elective Hip Surgery and Its Effect on Postoperative Pain and Length of Stay: A Multidisciplinary Prospective Randomized Double-blind Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Fribourgeois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Fribourgeois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effective postoperative pain management in elective hip surgery is crucial for the patients&#xD;
      well-being, rapid mobilisation and potential reduction of length of stay. In addition to&#xD;
      standard intravenous pain medication, anaesthetic blocks are reportedly effective. Recently,&#xD;
      the PENG block, a pericapsular pain block without impairment of the motor function has been&#xD;
      introduced in literature and performed at the investigator's hospital (HFR Fribourg,&#xD;
      Switzerland) for total hip arthroplasty and surgical hip dislocation - the two most commonly&#xD;
      performed elective hip surgeries.&#xD;
&#xD;
      As high-quality evidence on the effectiveness of this novel block is lacking, the&#xD;
      investigator's objective is to evaluate the effectiveness of (1) patient-reported pain&#xD;
      reduction, (2) total consumption of postoperative morphine, and the length of stay at the&#xD;
      hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty patients undergoing total hip arthroplasty and 40 patients undergoing surgical hip&#xD;
      dislocation will be enrolled in a prospective, double-blind, controlled trial performed at&#xD;
      the investigator's hospital.&#xD;
&#xD;
      This study will be the first prospective study evaluating the potential of this pain block in&#xD;
      elective hip surgery potentially affecting both patients' postoperative well-being and&#xD;
      optimizing costs of the hospital by reducing length of stay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Interdisciplinary, prospective, double-blind (participant and investigator), placebo-controlled, parallel-group study (experimental study, level of evidence I).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale (VAS)</measure>
    <time_frame>Reduction of postoperative pain in the first 24 hours after surgery</time_frame>
    <description>Using a ruler, the score is determined by measuring the distance (cm) on the 10-cm line between the &quot;no pain&quot; anchor and the patient's mark, providing a range of scores from 0 to 10. A higher score indicates greater pain intensity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption (morphine equivalent dose)</measure>
    <time_frame>Total consumption of postoperative morphine in the first 24 hours after surgery</time_frame>
    <description>Total morphine consumption in morphine equivalent dose (MED) in the fist 24 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay (days)</measure>
    <time_frame>Length of stay at the hospital (in days) from the day of the surgery (day 0) to the day of discharge, up to a maximum of 7 postoperative days</time_frame>
    <description>The length of hospital stay is measured in days, from the day of surgery (day 0) to the patient's discharge from the hospital. Discharge occurs up to a maximum of 7 days after surgery when the 3 following criteria are met: the scar must be dry, the pain must no longer require morphine and the patient must be able to walk with crutches</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>PENG block for anterior total hip arthroplasty or surgical hip dislocation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients will undergo the same preoperative, standardized protocol. Upon arrival to the operating theatre, routine, standard pre-medication will be applied before induction of general anesthesia. After intubation, the PENG block is performed. Under sonographic guidance, 20 mL of 0.5% ropivacaine iv is injected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo for anterior total hip arthroplasty or surgical hip dislocation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients will undergo the same preoperative, standardized protocol. Upon arrival to the operating theatre, routine, standard pre-medication will be applied before induction of general anesthesia. After intubation, the PENG block is performed. Under sonographic guidance, 20 mL of NaCL 0.9% is injected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PENG block</intervention_name>
    <description>All patients will undergo the same preoperative, standardized protocol. Upon arrival to the operating room, patients will be placed in supine position. Routine, standard pre-medication will be applied before induction of general anesthesia. After intubation, the PENG block is performed. Under sonographic guidance using a curvilinear probe, puncture will be performed in a lateromedial direction until the needle tip reaches the plane between the iliopsoas tendon and periosteum and between the anterior inferior iliac spine and iliopubic eminence. After a negative aspiration test, the blinded test item will be injected in the plane beneath the iliopsoas muscle. Patients will be randomly assigned to receive the test item (20 mL of ropivacaine 0.5%, Naropin). The anesthesiologist and the surgeon are blinded to the product injected.</description>
    <arm_group_label>PENG block for anterior total hip arthroplasty or surgical hip dislocation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>ll patients will undergo the same preoperative, standardized protocol. Upon arrival to the operating room, patients will be placed in supine position. Routine, standard pre-medication will be applied before induction of general anesthesia. After intubation, the PENG block is performed. Under sonographic guidance using a curvilinear probe, puncture will be performed in a lateromedial direction until the needle tip reaches the plane between the iliopsoas tendon and periosteum and between the anterior inferior iliac spine and iliopubic eminence. After a negative aspiration test, the blinded test item will be injected in the plane beneath the iliopsoas muscle. Patients will be randomly assigned to receive the placebo (20 mL of NaCL 0.9%). The anesthesiologist and the surgeon are blinded to the product injected.</description>
    <arm_group_label>Placebo for anterior total hip arthroplasty or surgical hip dislocation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Anterior total hip arthroplasty for hip osteoarthritis&#xD;
&#xD;
          -  Surgical hip dislocation for femoro-acetabular impingement (type cam-/pincer)&#xD;
&#xD;
          -  Age 16-85 years&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status 1 to 3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal/no informed consent&#xD;
&#xD;
          -  Inability to give informed consent&#xD;
&#xD;
          -  Lateral approach for total hip arthroplasty&#xD;
&#xD;
          -  Bilateral procedure&#xD;
&#xD;
          -  Additional osteotomies of the femur and/or acetabulum&#xD;
&#xD;
          -  Previous hip &amp; pelvis surgery&#xD;
&#xD;
          -  Chronic opioid users&#xD;
&#xD;
          -  Known allergy or intolerance to medications used in the trial (local anesthetic,&#xD;
             opioid)&#xD;
&#xD;
          -  Infection at the injection site&#xD;
&#xD;
          -  Body mass index &gt; 40kg/m2&#xD;
&#xD;
          -  Spinal anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthieu Hanauer, M.D.</last_name>
    <phone>+41263062810</phone>
    <email>matthieu.hanauer@h-fr.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>HFR Fribourg - Hôpital cantonal</name>
      <address>
        <city>Fribourg</city>
        <zip>1700</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007 Oct 27;370(9597):1508-19. Review.</citation>
    <PMID>17964352</PMID>
  </reference>
  <reference>
    <citation>Birnbaum K, Prescher A, Hessler S, Heller KD. The sensory innervation of the hip joint--an anatomical study. Surg Radiol Anat. 1997;19(6):371-5.</citation>
    <PMID>9479711</PMID>
  </reference>
  <reference>
    <citation>Guay J, Parker MJ, Griffiths R, Kopp S. Peripheral nerve blocks for hip fractures. Cochrane Database Syst Rev. 2017 May 11;5:CD001159. doi: 10.1002/14651858.CD001159.pub2. Review. Update in: Cochrane Database Syst Rev. 2020 Nov 25;11:CD001159.</citation>
    <PMID>28494088</PMID>
  </reference>
  <reference>
    <citation>Girón-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.</citation>
    <PMID>30063657</PMID>
  </reference>
  <reference>
    <citation>Cuschieri S. The CONSORT statement. Saudi J Anaesth. 2019 Apr;13(Suppl 1):S27-S30. doi: 10.4103/sja.SJA_559_18. Review.</citation>
    <PMID>30930716</PMID>
  </reference>
  <reference>
    <citation>Pascarella G, Costa F, Del Buono R, Pulitanò R, Strumia A, Piliego C, De Quattro E, Cataldo R, Agrò FE, Carassiti M; collaborators. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial. Anaesthesia. 2021 Nov;76(11):1492-1498. doi: 10.1111/anae.15536. Epub 2021 Jul 1.</citation>
    <PMID>34196965</PMID>
  </reference>
  <reference>
    <citation>Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ. 2013 Jan 21;346:e8668. doi: 10.1136/bmj.e8668.</citation>
    <PMID>23338004</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 28, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Fribourgeois</investigator_affiliation>
    <investigator_full_name>Matthieu Hanauer</investigator_full_name>
    <investigator_title>Attending surgeon, M.D.</investigator_title>
  </responsible_party>
  <keyword>PENG block</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Elective hip surgery</keyword>
  <keyword>Total hip arthroplasty</keyword>
  <keyword>Surgical hip dislocation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The IPD and results of this study will be presented at national and international orthopedic meetings and will be submitted to highly-ranked peer reviewed orthopedic journals.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The study will start in January 2022 and summary data will be published.</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

